ASX-Dividend-Report-Banner

First procedure in Netherlands with NaoTrac surgical navigation robot is performed at Erasmus MC Rotterdam

July 17, 2024 05:49 PM AEST | By Cision
 First procedure in Netherlands with NaoTrac surgical navigation robot is performed at Erasmus MC Rotterdam
Image source: Kalkine Media

HSINCHU, July 17, 2024 /PRNewswire/ -- Brain Navi announces the completion of its first case in Netherlands, which was successfully and safely performed at Erasmus MC in Rotterdam, Netherlands.

Brain biopsy helps doctors decide the best treatment for the patient after taking a tissue sample from the brain, usually under general anesthetic.

To avoid long and frustrating registration process, NaoTrac incorporates machine vision technology, and finishes the patient and instrument registrations within 30 seconds to 3 minutes. It is an open platform, and the instrument registration is performed by the robotic arm automatically, much safer and faster.

This milestone of Brain Navi from Netherlands comes only a few months after the company announced its completion of 100 clinical case using NaoTrac.

First case, the brain tumor biopsy, using NaoTrac in Erasmus MC, Netherlands
First case, the brain tumor biopsy, using NaoTrac in Erasmus MC, Netherlands

NaoTrac reached to the lesion and neurosurgeon is taking out the tissue sample.
NaoTrac reached to the lesion and neurosurgeon is taking out the tissue sample.

"We are thrilled to be working with The Neurosurgery Department of Erasmus MC to demonstrate the value that NaoTrac could bring to Dutch market. Moving forward, we aim to expand our presence in other parts of Europe, introduce this novel technology to help more surgeons and patients." said Dr. Jerry Chen, the CEO of Brain Navi.

Dr. Arnaud Vincent, the neurosurgeon from Erasmus MC also gave his feedback after the first surgery performed in the center. "The first surgery went very well, very easy, very quick, the procedure was less than an hour. The patient recovered very well and we have very precise biopsy of the tumor."

About Erasmus MC:
Erasmus Medical Center is the largest and one of the most trusted scientific medical centers in Europe. Both in terms of turnover and number of beds, the hospital is the largest of the eight university medical centers in the Netherlands. 

About Brain Navi:
Brain Navi Biotechnology, a leading Taiwanese surgical robotic company, specializes in designing and developing innovative navigation and robotic surgery technologies. Their proprietary Surface Mapping Auto-Registration Technology (SMART) represents a significant surgical breakthrough, integrating machine vision, robotics, and AI for streamlined surgical procedures and real-time imaging, ensuring minimal invasive outcomes. NaoTrac's swift patient registration, and automatic surgical instrument registration enable surgeons to plan trajectories effortlessly, and the robot ensures precise autonomous navigation towards the desired target.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.